Experts discuss how synthetic growth factors work and share application examples and data using these synthetic peptides for cell therapy and regenerative medicine.
The production of conventional growth factors and cytokines for regenerative medicine, cell therapy products, and cultivated meat is faced with challenges such as lot-to-lot quality variation, contamination, low stability, and high manufacturing costs. PeptiGrowth Inc. has developed synthetic peptides that offer a solution to these challenges while still retaining the same capabilities of receptor activation, cell proliferation, and differentiation as conventional growth factors.
In this webinar, Dr. Kosuke Minamihata and Dr. Jes Kuruvilla share application examples of synthetic peptide growth factors in cell culture models and the key benefits of using their products.
Presenters
Kosuke Minamihata
Kosuke Minamihata earned his PhD in protein engineering from Kyushu University in Japan, with a focus on site-specific modification of proteins using enzymatic reactions. He joined the University of Tokyo and worked as a Postdoctoral Fellow and Assistant professor for 3.5 years. Then, he joined Kyushu University in 2016 as a Research Associate and helped set up KAICO Ltd., which provides growth factors and contracted protein synthesis service using silkworm-baculovirus expression systems. He was a part of the sales and development team at KAICO Ltd, for 2 years. He returned to Kyushu University as a full-time Assistant Professor in 2020 before joining his current position at PeptiGrowth-Mitsubishi in October 2022, where he is the Technical Support Manager for marketing.
Jes Kuruvilla
Jes Kuruvilla received his PhD in Cell and Molecular Biology with a background in developing humanized animal models for studying viral infections. During his post-doctoral fellowships he gathered expertise in studying stem cells of the gastrointestinal (GI) tract and its regeneration in response to radiation damage. He transitioned into the industry supporting stem cell scientists to develop various iPSC and hES lines as well as adult stem cells into organoids over the recent years. In MIFI Bioceuticals, he is in charge of business development for PeptiGrowth’s unique synthetic peptide growth factors in North America. MIFI Bioceuticals is a division of Mitsubishi International Food Ingredients, based in NJ, the USA.
Sponsor
PeptiGrowth, Inc.
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
